Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FOCUS 3 - A Study to Determine the Feasibility of Molecular Selection of Therapy Using KRAS, BRAF and Topo-1 in Patients With Metastatic or Locally Advanced Colorectal Cancer

NCT00975897 is registered in ClinicalTrials.gov with Medical Research Council as lead sponsor.

NCT NCT00975897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00975897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FOCUS 3 - A Study to Determine the Feasibility of Molecular Selection of Therapy Using KRAS, BRAF and Topo-1 in Patients With Metastatic or Locally Advanced Colorectal Cancer
Lead sponsor
Medical Research Council
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2009
Completion date
December 31, 2012
Enrollment
3,240 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer